Best IDEA Pharma Podcasts (2024)

1
EP 143: Jordi Ferrer Rendé - Is Healthcare Destroying the Planet? The Shocking Truth About CO2 Emissions 2:05:26

14h ago2:05:26

2:05:26

Artificial intelligence is revolutionizing healthcare, but what if the real danger lies in the industry's carbon footprint? Despite healthcare’s purpose of saving lives, the industry contributes up to 10% of CO2 emissions in developed countries. Can patient care and sustainability go hand in hand, or are we risking the planet's health for human sur…

1
Biotech Course Correction With Treehill Partners' Ali Pashazadeh 1:17:16

5d ago1:17:16

1:17:16

We love to hear from our listeners. Send us a message. It wouldn't be accurate to say that surgeon-turned-healthcare investment banker and consultant Dr. Ali Pashazadeh traded his scalpels for spreadsheets. In fact, he still wields a scalpel quite frequently, and on this episode of the Business of Biotech podcast, he offers a fantastic reason why. …

1
EP 142: Angeli Moeller - Why AI Isn’t Transforming Healthcare Like It Should 2:10:31

11d ago2:10:31

2:10:31

Artificial intelligence is heralded as the future of healthcare, but why do so many innovations fail to make a tangible impact? Despite the hype, countless companies are missing critical opportunities to leverage AI effectively. What’s holding them back? In this episode, Angeli Möller, CEO of Sequoia Growth, reveals why healthcare AI often falls sh…

1
An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D. 1:14:26

12d ago1:14:26

1:14:26

We love to hear from our listeners. Send us a message. Hilary Eaton, Ph.D. was a self-described AI skeptic, particularly as it relates to using the tool in drug discovery. Then, a series of professional and deeply personal life events and medical discoveries put her in a position to confront that skepticism head-on. Today, she's Chief Business Offi…

1
#23 — Is ADHD permanent? 13:32

16d ago13:32

13:32

Is ADHD fixed? Or is it fluid? Does it change? Can it be severe and intense for a while? And then (almost) non-existent later? The answer is yes. I know this for certain because I experience it myself. And dozens of my 1:1 clients have experienced the same thing after learning the Drug Free ADHD method. In this solo episode I dig into the fluidity …

1
Picking Biotech Jockeys With SR One's Simeon George, M.D. 54:03

20d ago54:03

54:03

We love to hear from our listeners. Send us a message. SR One Capital Management CEO Simeon George, M.D. has a seemingly innate ability to pick winning biotech builders. Early on, he and his firm got behind CRISPR's Samarth Kulkarni, Ph.D., Arcellx' Rami Elghandour, and Nkarta's Paul Hastings, for example. With nearly 50 biotech leaders in SR One's…

1
EP 141: Alessandro Morra - How AI-Powered Robotics Will Transform Security—Are You Prepared for the Future? 1:50:46

20d ago1:50:46

1:50:46

Many companies today face increasing security challenges, yet few are leveraging the power of AI and robotics to protect their most critical assets. But what if these groundbreaking technologies could not only reduce costs but also provide a more efficient and secure future? In this episode, Alessandro Morra, CEO of Ascento, shares how AI-powered r…

1
Embracing Biotech Chaos With Memo's Erik van den Berg 54:05

27d ago54:05

54:05

We love to hear from our listeners. Send us a message. Erik van den Berg is CEO and board member at Memo Therapeutics, and he's a student of biotech chaos. In fact, he's been embracing it with intention for the past 30 years. On this episode of the Business of Biotech, he walks us through the management of that chaos in specific detail. Navigating …

1
#140: Customer Obsession Isn’t Enough—What Jeff Bezos Knows That Most Leaders Miss 1:29:50

27d ago1:29:50

1:29:50

What’s the secret to building a trillion-dollar company from scratch? In this episode, we uncover Jeff Bezos' game-changing strategies from Invent and Wander, revealing how Amazon became a global powerhouse. In the world of business and investing, visionary ideas alone are not enough. Invent and Wander reveals that it's a relentless focus on long-t…

1
Pivoting To RNA With Circio's Dr. Erik Digman Wiklund 1:04:47

1M ago1:04:47

1:04:47

We love to hear from our listeners. Send us a message. This week, it’s another “Business of Biotech-meets-Business-of-RNA” takeover with Circio CEO Erik Digman Wiklund, Ph.D. and guest co-host Anna Rose Welch of Advancing RNA. While Circio’s legacy is in cancer immunology (it still boasts a cancer vaccine candidate targeting KRAS driver mutations),…

1
mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D. 1:03:07

1M ago1:03:07

1:03:07

We love to hear from our listeners. Send us a message. Guest co-host Anna Rose Welch of Advancing RNA fame joins us on this week’s Business of Biotech podcast for a conversation with the leaders of RNA upstart Radar Therapeutics. The company’s co-founders, Eerik Kaseniit, Ph.D. (CSO & President) and Sophia Lugo (CEO), are making waves in the mRNA t…

1
EP 139 - Marc Penkala - Why European Startups Must Think Bigger: Lessons from a Top VC on Turning Failure into Fortune 1:59:07

1M ago1:59:07

1:59:07

Many European startups are trapped in a mindset that limits their potential, aiming for millions when they should be thinking in billions. But what if this conservative approach is holding them back from global success? In this episode, Marc Penkala, a leading venture capitalist, reveals the secrets to breaking free from this limiting mindset and h…

1
Steering Through Setbacks with AVEO Oncology's Michael Bailey 58:06

2M ago58:06

58:06

We love to hear from our listeners. Send us a message. For all the drug commercialization successes he's played a leading hand in during his tenures at GSK, Genentech, and ImClone—Androderm, Augmentin, necitumumab, and Erbitux among them—Michael Bailey concedes that he's likely better known for his failures. After hearing his stories on this episod…

1
#138: The PayPal Blueprint: How Vision Without a Business Model Nearly Sunk a Tech Giant 1:16:27

2M ago1:16:27

1:16:27

Ever wondered what it takes to build a tech giant from the ground up? Is it just about having a great idea, or is there a secret formula for success? In this episode, we dive into Jimmy Soni's The Founders, uncovering the key principles that propelled PayPal from a fledgling startup to a cornerstone of the digital economy. In the world of investing…

1
Leading From Within with ISCT & Kiji's Miguel Forte, M.D. 59:37

2M ago59:37

59:37

We love to hear from our listeners. Send us a message. He's been a big pharma executive. He's a multi-time biotech founder and current biotech CEO. He was once a regulator. He's a physician. He serves on multiple boards. And as of this summer, he's president of one of the most influential global organizations dedicated to the advance of cell and ge…

1
#22 — Becoming an independent business owner: Carly Brinkman 48:34

2M ago48:34

48:34

In this episode, I interview Carly Brinkman. Carly is my client. But our coaching relationship isn't all one way. Carly is an extremely open soul, who has opened my mind up to In this episode we discuss: How to build a sustainable business (with ADHD) How to decide what is enough How to remain independent Not identifying as ADHD How to be controv…

1
The Allogeneic Future with Poseida's Kristin Yarema, Ph.D. 1:04:44

2M ago1:04:44

1:04:44

We love to hear from our listeners. Send us a message. Kristin Yarema, Ph.D. thinks the progress of CAR T therapeutics is allogeneic. In fact, she says CAR T-cell therapies have to become a one-to-many proposition, if their early autologous success can possibly live up to the promise of offering widespread accessibility to life-saving treatments. D…

1
Expanding The Proteome with ProFound's John Lepore, M.D. 56:38

2M ago56:38

56:38

We love to hear from our listeners. Send us a message. Flagship Pioneering’s ProFound Therapeutics is on to something, and it could be something big. It began with a simple question: What if more RNAs were being translated into proteins? Answering that question took ProFound deep into the translatome, where it’s now studying the full compendium of …

1
EP 137: Hampus Jakobsson - The Secret to Venture Success: Investing in People, Not Just Ideas 2:12:16

2M ago2:12:16

2:12:16

Did you know the secret to venture success isn't just in groundbreaking ideas? It's in the people behind them. Learn how empathy and grit fuel extraordinary success in this insightful episode. Many investors fail by only chasing ideas. Discover why focusing on the right founders can unlock revolutionary outcomes. Join us as Hampus Jakobsson reveals…

1
#21 — Corruption and the lies of Big Pharma: Kerry Munro 53:12

2M ago53:12

53:12

An interview with Kerry Munro, an Occupational Therapist and outdoor enthusiast who runs the Instagram account @minds.first In this episode we discuss: The corruption of Big Pharma The downsides of psychiatry The benefits of clinical psychology Wild swimming And the benefits of living near nature Enjoy!…

1
From The Bench To The Boardroom with ImmunityBio's Enrique Diloné 1:06:39

3M ago1:06:39

1:06:39

We love to hear from our listeners. Send us a message. While organic chemistry lectures caused many of his peers at NYU to wring their hands, gnash their teeth, and question life choices, then-19-year-old Enrique Diloné ate those classes for lunch. They inspired him to earn a Seton Hall Ph.D. in chemistry, and to go to work as a big bio research sc…

1
First AI Antibody In Humans with Aulos' Aron Knickerbocker 1:08:52

3M ago1:08:52

1:08:52

We love to hear from our listeners. Send us a message. Data drives decision-making at Aulos Bioscience. It's also driven the career trajectory of its CEO. On this week's episode of the Business of Biotech podcast, we get an introspective walk through Aron Kinickerbocker's strategically-orchestrated career path, from his early days in the labs at Br…

1
EP 136: Focus and Determination: Lessons from Dan Brisse's Sports and Business Career 1:58:52

3M ago1:58:52

1:58:52

Discover how Dan Brisse, a former X Games gold medalist, transformed his passion for snowboarding into a thriving real estate empire. In this episode of [Podcast Name], we delve deep into Dan's journey, exploring the resilience, focus, and determination that propelled him from professional sports to building Granite Towers Equity Group. 🎙️ What's i…

1
Drug Delivery Differentiators with Syncromune's Eamonn Hobbs 1:12:31

3M ago1:12:31

1:12:31

We love to hear from our listeners. Send us a message. Syncromune's Sync-T solid tumor therapeutic platform is, in a word, complex. The company's three phase 1 programs combine T-cell science with a proprietary drug delivery device to target solid tumors, specifically metastatic breast, non-small-cell lung, and castrate-resistant prostate cancers. …

1
Journey of Leadership with Lars Dreesmann, President of Boehringer Ingelheim Fremont | Ep79 34:48

3M ago34:48

34:48

In this episode, we dive into the fascinating journey of Lars Dreesmann, President of Boehringer Ingelheim Fremont. Join us as Lars shares his story of growth, from his early interest in biology to his transition into the pharmaceutical industry, and the challenges he faced relocating to California during the pandemic. Learn about his role at Boehr…

1
#135: Empowering Innovators: 10 Lessons from The Innovators by Walter Isaacson 1:18:56

3M ago1:18:56

1:18:56

Ever wondered how the digital revolution came to be? Was it the work of lone geniuses, or was there something more at play? In this episode, we delve into Walter Isaacson's "The Innovators," uncovering the collaborative efforts and key principles that have shaped our technological landscape. In the world of investing and entrepreneurship, building …

1
Topical Ocular Biologics with Claris Bio's Clarke Atwell 58:06

3M ago58:06

58:06

We love to hear from our listeners. Send us a message. Built on the back of hepatocyte growth factor discoveries by Harvard Drs. Reza Dana and Sunil Chauhan, ClarisBio is rewriting the ophthalmology rulebook. CEO Clark Atwell acknowledges that it's not the first to bring topically-administered biologic therapies to the front of the eye, but if succ…

1
C&G Regulatory Guidance with Lineage Therapeutics' Brian Culley 1:04:02

3M ago1:04:02

1:04:02

We love to hear from our listeners. Send us a message. When we last caught up with Brian Culley, CEO at Lineage Cell Therapeutics, it was January, 2021. A pandemic was raging. His company was moving mountains to keep its OpRegen dry AMD clinical trial together, and did so despite lockdowns that kept a largely aged patient population from setting fo…

1
EP 134 - The Secret Sauce of California’s Biotech Success Revealed by Joe Panetta 1:03:26

4M ago1:03:26

1:03:26

🚀 Discover the Secret Sauce Behind California’s Biotech Success with Joe Panetta Unlock the keys to California’s biotech boom as we delve into the insights of Joe Panetta, President and CEO of Biocom California. In this episode, we explore the unique factors that have made California a global leader in biotech innovation. Whether you’re a CEO, inve…

1
#20 — Making Meditation Simple 16:22

4M ago16:22

16:22

There's a common fallacy in ADHD circles that we can't meditate. It's not true. We can, we've just been taught wrong. Meditation is simple. It's the repetitive process of focusing on an object of attention (a mantra). In this episode I explain the meditation technique I teach to all Drug Free ADHD clients. It's specifically designed for ADHD brains…

1
True DEI Value in Biopharma with Arcellx's Rami Elghandour 1:04:08

4M ago1:04:08

1:04:08

We love to hear from our listeners. Send us a message. The cell therapy company Arcellx has, by any and every measure, been outperforming its peers. Its stock has rallied on the back of the strong performance of its multiple myeloma candidate, and the promise of its AML, MDS, and solid tumor pipelines is attracting the kind of interest it takes to …

1
MM 22: Solving Big Problems: Luis Pareras on Smart Investments 6:55

4M ago6:55

6:55

Are you ready to discover the secret behind successful investments? Join us as we delve into the mind of Luis Pareras, a venture capital expert, as he reveals the critical investment principle many founders overlook. 🚀 What if the key to successful investments isn't just about having a solution, but finding the right problem to solve? 🎙️ In this Cl…

1
EP 133: Suzanne Heywood - From Shipwreck to Boardroom: How Education Transformed a Life of Adversity into Extraordinary Success 1:53:13

4M ago1:53:13

1:53:13

Imagine spending a decade of your childhood adrift at sea, facing shipwreck and isolation. Could you turn that adversity into a springboard for a remarkable career? Suzanne Heywood, COO of Exor and author of the captivating memoir "Wavewalker," did just that. In this episode, we unpack her incredible journey from a life of hardship to leading a glo…

1
From CRA to SVP: Guide to Seizing Opportunities in Pharma | Ep78 38:19

4M ago38:19

38:19

Adina Pelusio, SVP of Clinical Operations at Kalivir Immunotherapeutics. Adina's journey from a chance job offer to a leading role in biotech is nothing short of motivational. Learn how she navigated her career, the value of saying 'yes' to opportunities, and the importance of mentorship.By huxleymorton

1
#19 — Getting off meds in 3 months | Carly Watson 51:03

4M ago51:03

51:03

This is a unique episode for the Drug Free ADHD podcast. I interview Carly Watson, a coaching client who, after perfectly executing the Drug Free ADHD toolkit, managed to kick the meds for good (in just 3 months). We talk about: Brutal ADHD meds side effects Using ice baths to boost dopamine How meditation settles the mind Breathwork to calm the mi…

1
Mission-Driven Dementia Funding with DDF's Jonathan Behr 55:46

4M ago55:46

55:46

We love to hear from our listeners. Send us a message. If there's anyone qualified to analyze an early-stage therapeutic technology and place bets with other people's money, it's scientist-turned-venture capitalist Jonathan Behr, Ph.D. He built a distinguished venture capital career on the back of an MIT Ph.D. in biological engineering, having co-f…

1
#132: Mastering Risk and Failure: Jeff Bezos' Blueprint for Success (Biography Review) 1:01:14

4M ago1:01:14

1:01:14

Ever wondered how Jeff Bezos transformed a humble online bookstore into the global powerhouse that is Amazon? This biography summary by Influential Individuals uncovers the core principles that propelled Bezos to become the world's richest person. In my martial arts days, a coach taught me to study exceptional role models – a strategy akin to the f…

1
ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller 1:04:06

4M ago1:04:06

1:04:06

We love to hear from our listeners. Send us a message. Just a few years ago, Daiichi Sankyo wasn't considered a player in the oncology therapeutics space, and it certainly wasn't a player in ADCs. But then, just a few years ago, who was? Fast forward to 2023, and we see an ADC arena that drove nearly $100 billion in M&A, licensing, and partnership …

1
EP 131: 🚀 Fast Forward Thinking: Luis Pareras on Future and Science-Driven Innovation 2:17:25

4M ago2:17:25

2:17:25

Unlock the secrets of future-proof investing and transformative innovation in this compelling episode. Join us as we delve into the mind of Luis Pareras, Managing Partner at Invivo Partners, a venture capital fund pioneering investments in cutting-edge biotech. Discover how to navigate the rapidly evolving landscape of science and technology to dri…

1
Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D. 56:38

4M ago56:38

56:38

We love to hear from our listeners. Send us a message. Mythic Therapeutics Chief Scientific Officer and co-founder Brian Fiske, Ph.D. broke some unwritten protocol with his rapid and multifaceted transition from academia to industry. He calls his many, and sometimes concurrent, early experiences as an MIT Ph.D. student, a Flagship Ventures Fellow, …

1
Redefining Consulting in Biotech and Pharma: The Alcoa Approach | Ep77 38:34

5M ago38:34

38:34

This week, we talk to Robert Goldman and Justin Rudolph from Alcoa Consulting about their innovative two-for-one consulting model. If you're a biotech startup or a large CRO, this episode is packed with insights on how to leverage experienced consultants without breaking the bank. Their 360-degree experience in biotech and CRO industries is a game-…

1
Ep 130: Is Venture Debt the Missing Piece in Your Startup's Funding Puzzle? (EIB's Expert Reveals All) 33:06

5M ago33:06

33:06

What if there was a funding source that could supercharge your startup's growth without diluting your equity? It's not a pipe dream. It's venture debt – a powerful tool that many founders and investors haven't fully explored. In this episode, we channel the spirit of learning from industry leaders, just as in the famous Harvard Business Cases. We d…

1
The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch 57:35

5M ago57:35

57:35

We love to hear from our listeners. Send us a message. This isn't your typical drug sponsor + CDMO story. In fact, CTMC's Jason Bock, Ph.D. says you shouldn't even classify his company a CDMO. He's not wrong. While some of the company's services aren't dissimilar from those offered by a contract developer, CTMC began with a more fundamental mission…

1
A New Prescription For PBMs with Allan Shaw 40:13

5M ago40:13

40:13

We love to hear from our listeners. Send us a message. Back by popular demand, biopharma industry opinionator extraordinaire Allan Shaw rejoins the Business of Biotech to expose the murky role Pharmacy Benefit Managers (PBMs) play in the last, costly mile of the drug distribution supply chain. Allan pulls no punches in his criticism of the current …

1
#129: Elon Musk Leadership Formula: Risk, Ambition, and the Cost of Success (Walter Isaacson Biography Review) 1:24:50

5M ago1:24:50

1:24:50

Ever wondered what drives Elon Musk, the world's most controversial innovator? This biography summary by Walter Isaacson dives into the complex mind of the man behind rockets, EVs, and the Twitter takeover. In my martial arts days, a coach taught me to study exceptional role models – a strategy akin to the famous Harvard Business Cases. Analyze suc…

1
IDEA Collider- with IDEA Pharma COO Jacqueline Barendregt and Exploristics Founder & CEO Aiden Flynn 18:33

5M ago18:33

18:33

We are excited to tell you more about the IDEA Pharma and Exploristics partnership. IDEA’s COO, Jacqui Barendregt, asked Exploristics Founder and CEO Aiden Flynn five key questions about the innovative service model and, most importantly, the value to the pharmaceutical industry this newly formed partnership will bring.…

1
New Apps For AI in mRNA With Anima Biotech's Yochi Slonim 59:10

5M ago59:10

59:10

We love to hear from our listeners. Send us a message. From San Francisco’s Silicon Valley to Tel Aviv’s Silicon Wadi, software business entrepreneur Yochi Slonim made a name for himself in global tech hubs around the globe. Notably, he was co-founder of billion-dollar Mercury Interactive, which HP acquired for $4.5 billion, and previous to that a …

1
Navigating Career Growth and Change in the Pharma Industry | Ep76 46:19

5M ago46:19

46:19

Networking is key in today's job market! Chiara Invernizzi shares invaluable insights on leveraging LinkedIn and building connections to advance your career. From moving countries to navigating different corporate cultures today we hear Chiara’s challenges and triumphs.By huxleymorton

1
Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch 59:11

5M ago59:11

59:11

We love to hear from our listeners. Send us a message. As if Orna Therapeutics' CEO Thomas Barnes, CEO isn't a enough to draw you in to the Business of Biotech, we teamed up with Advancing RNA Editorial & Community Director Anna Rose Welch to co-host this week's episode. Together, Anna Rose and I press Dr. Barnes on his transition from academia to …

1
#18 — Making peace with procrastination 10:04

5M ago10:04

10:04

Procrastination. That word leaves me in a cold sweat. Endless hours staring at a blank piece of paper. Full workdays lost to YouTube. Anything at all to avoid doing the one thing I should do. I used to fear it. But I don't any longer. This week's podcast - a solo episode from me - explains my entire process for dealing with weapons grade procrastin…

Podcasts Worth a Listen

IDEA Pharma Podcasts

Podcasts Worth a Listen

Quick Reference Guide